Last update:

Oncology & Cancer news

Oncology & Cancer

New imaging technique accurately detects aggressive kidney cancer

A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form ...

Oncology & Cancer

Study ties diabetes and obesity to increased risk of liver cancer relapse

Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal. Recent advances in antiviral therapy have reduced the number of patients ...

Oncology & Cancer

Gene activation linked to severity of a rare lung cancer

Pulmonary carcinoids are rare tumors of the lung with extremely different clinical courses. In many patients, they behave like benign tumors; surgical removal of the tumor leads to a complete cure. However, some patients ...

Oncology & Cancer

Categorizing the epigenetic hallmarks that define cancer

Cancer mortality has just surpassed cardiovascular disease for the first time ever and one in two men, and one in three women, will be diagnosed with some form of the disease in the US, according to the NIH.

Oncology & Cancer

Report explores the role alcohol plays in new cancer cases

A little bit of alcohol was once thought to be good for you. However, as scientific research advances, we're gaining a clearer picture of alcohol's effect on health—especially regarding cancer.

Oncology & Cancer

The role of p53 as a target for novel cancer therapies

The p53 tumor suppressor protein is encoded by TP53, the most frequently mutated gene in cancer. A review article published in Nature Reviews Clinical Oncology by Professor Klas G Wiman and colleagues at the Department of ...

Oncology & Cancer

Genomic data shed light on how lymphoma can turn lethal

A study by researchers at Columbia and the Hong Kong University of Science and Technology is helping to clarify how low-grade lymphoma changes as it develops into a more aggressive tumor, which could lead to the development ...

Oncology & Cancer

Secret vulnerabilities of cancer's 'Death Star' protein revealed

Researchers at the Center for Genomic Regulation in Barcelona, Spain, and the Wellcome Sanger Institute near Cambridge, UK, have comprehensively identified the allosteric control sites found in the protein KRAS. These are ...

Oncology & Cancer

Unraveling predisposition in bilateral Wilms tumor

Children with bilateral Wilms tumor have a tumor in each of their kidneys—a condition that strongly suggests an underlying genetic or epigenetic predisposition driving the disease. Scientists at St. Jude Children's Research ...

Oncology & Cancer

Efficacy shown for new melanoma therapeutic vaccine

In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.

Oncology & Cancer

Novel therapeutic target overcomes resistance to radiation therapy

A new study finds that radiation therapy (RT) suppresses a key protein called bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and activates immune suppressive cells. These effects dampen the capacity ...

Medical research

PFAS pollutants promote cancer cell migration: Study

In a new study by researchers at the Yale School of Public Health, two "forever chemicals" spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis ...

Oncology & Cancer

Study identifies strategy to avoid resistance to cancer therapy

Resistance to therapies is one of the obstacles to overcome in cancer treatments. Understanding the mechanisms of this resistance is essential to design strategies that favor tumor cell death. A study led by the Protein Kinases ...

Oncology & Cancer

Moderna CEO says melanoma vaccine could be available by 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.